EI
UTHR icon

Ethic Inc’s United Therapeutics UTHR Stock Holding History

Ethic Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$834K Buy
1,539
+461
+43% +$260K 0.01% 772
2026
Q1 		$639K Buy
1,078
+122
+13% +$60.8K 0.01% 784
2025
Q4 		$466K Buy
956
+83
+10% +$38.7K 0.01% 871
2025
Q3 		$366K Sell
873
-28
-3% -$9.42K 0.01% 936
2025
Q2 		$256K Buy
901
+104
+13% +$31.1K ﹤0.01% 1033
2025
Q1 		$245K Sell
797
-1,921
-71% -$658K 0.01% 1008
2024
Q4 		$959K Buy
+2,718
New +$999K 0.02% 619
2024
Q1 		– Sell
-1,379
Closed -$303K – 1136
2023
Q4 		$303K Buy
1,379
+344
+33% +$79.3K 0.01% 868
2023
Q3 		$234K Buy
+1,035
New +$238K 0.01% 886
2022
Q2 		– Sell
-2,472
Closed -$444K – 794
2022
Q1 		$444K Buy
+2,472
New +$471K 0.03% 495

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Ethic Inc's UTHR Position: Q2 2026 in Review

Ethic Inc increased its United Therapeutics (UTHR) stake by 43% in Q2 2026, buying an estimated $260K and bringing the position to 1,539 shares worth $834K. The position accounts for 0.01% of the portfolio, ranked #772.

Ethic Inc first reported a position in UTHR in Q1 2022 and has held it in 10 quarters since. The position peaked at $959K in Q4 2024. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Ethic Inc held 1,539 shares of United Therapeutics worth $834K as of Q2 2026.
  • Ethic Inc bought 461 United Therapeutics shares in Q2 2026, an estimated $260K.
  • United Therapeutics made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #772 holding.
  • Ethic Inc first reported a position in United Therapeutics in Q1 2022 and has held it in 10 quarters since.
  • Ethic Inc's United Therapeutics position peaked at $959K in Q4 2024.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.